TrialJournal of child and adolescent psychopharmacology2023

Safety and Tolerability of Serdexmethylphenidate/Dexmethylphenidate Capsules in Children with Attention-Deficit/Hyperactivity Disorder: A 12-Month, Open-Label Safety Study.

Ann C Childress et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.